Dyax Corp. has secured $50 million in financing, shoring up cash options as the company gears up for potential regulatory approval of its lead drug.

Lees meer..

Mylan Inc. reported Thursday that its third-quarter earnings were up, buoyed by the sale of the rights to blood pressure drug Bystolic. (MYL)

Lees meer..

Redwood City’s Genelabs Technologies Inc. has agreed to be bought by GlaxoSmithKline for about $57 million. (GSK) (GNLB)

Lees meer..

Unisys Corp. posted an even larger loss in the third quarter than in the third quarter a year ago, despite the fact that analysts were expecting it to turn a profit. (UIS)

Lees meer..

GlaxoSmithKline entered into a definitive agreement Thursday to buy Genelabs Technologies Inc. for $57 million. (GSK) (GNLB)

Lees meer..

GlaxoSmithKline will purchase Genelabs Technologies Inc. for about $57 million, or $1.30 per share, the companies said late Wednesday. (GSK) (GNLB) (GILD)

Lees meer..

Advanced Cell Technology Inc. said Thursday an Irish investor has upped its funding commitment to the company by $500,000.

Lees meer..

The F. Dohmen Co. Foundation has announced donations totaling $750,000 to the University of Wisconsin-Madison and the Wisconsin Historical Society.

Lees meer..

GlaxoSmithKline, on a quest to strengthen its drug pipeline, on Thursday announced its fourth significant acquisition this month – a $57 million purchase of Redwood City, Calif.-based Genelabs Technologies. (GSK)

Lees meer..

Alnara Pharmaceuticals Inc. has landed $20 million in a first round of venture capital financing to accelerate development of new treatments for metabolic and inflammatory diseases.

Lees meer..